Generation of new cytotoxic human ribonuclease variants directed to the nucleus

Molecular Pharmaceutics

Volumn 9, Issue 10, 2012, Pages 2894-2902

  Vert, Anna ^a,b   Castro, Jessica ^a,b   Ruiz Martínez, Santiago ^a,b   Tubert, Pere ^a,b   Escribano, Diego ^a,b   Ribó, Marc ^a,b   Vilanova, Maria ^a,b   Benito, Antoni ^a,b  

^a Departament de Biologia   (Spain)

^b GIRONA BIOMEDICAL RESEARCH INSTITUTE IDIBGI   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; RIBONUCLEASE; RIBONUCLEASE PE5; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CYTOTOXICITY; DRUG POTENCY; IMMUNOGENICITY; MUTATION; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL;

EID: 84870205367     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp300217b     Document Type: Article

References (41)

1. Ribó, M.; Benito, A.; Vilanova, M. Antitumor ribonucleases. In Ribonucleases, 1 st ed.; Nicholson, A. W., Ed.; Springer-Verlag: Berlin, 2011; pp 55-88.
2. Darzynkiewicz, Z.; Carter, S. P.; Mikulski, S. M.; Ardelt, W. J.; Shogen, K. Cytostatic and cytotoxic effects of Pannon (P-30 Protein), a novel anticancer agent Cell Tissue Kinet. 1988, 21 (3) 169-182
3. Deptala, A.; Halicka, H. D.; Ardelt, B.; Ardelt, W.; Mikulski, S. M.; Shogen, K.; Darzynkiewicz, Z. Potentiation of tumor necrosis factor induced apoptosis by onconase Int. J. Oncol. 1998, 13 (1) 11-16
4. Halicka, H. D.; Murakami, T.; Papageorgio, C. N.; Mittelman, A.; Mikulski, S. M.; Shogen, K.; Darzynkiewicz, Z. Induction of differentiation of leukaemic (HL-60) or prostate cancer (LNCaP, JCA-1) cells potentiates apoptosis triggered by onconase Cell Proliferation 2000, 33 (6) 407-417
5. Ita, M.; Halicka, H. D.; Tanaka, T.; Kurose, A.; Ardelt, B.; Shogen, K.; Darzynkiewicz, Z. Remarkable enhancement of cytotoxicity of onconase and cepharanthine when used in combination on various tumor cell lines Cancer Biol. Ther. 2008, 7 (7) 1104-1108
6. Kim, D. H.; Kim, E. J.; Kalota, A.; Gewirtz, A. M.; Glickson, J.; Shogen, K.; Lee, I. Possible mechanisms of improved radiation response by cytotoxic RNase, Onconase, on A549 human lung cancer xenografts of nude mice Adv. Exp. Med. Biol. 2007, 599, 53-59
7. Mikulski, S. M.; Viera, A.; Darzynkiewicz, Z.; Shogen, K. Synergism between a novel amphibian oocyte ribonuclease and lovastatin in inducing cytostatic and cytotoxic effects in human lung and pancreatic carcinoma cell lines Br. J. Cancer 1992, 66 (2) 304-310
8. Ramos-Nino, M. E.; Littenberg, B. A novel combination: ranpirnase and rosiglitazone induce a synergistic apoptotic effect by down-regulating Fra-1 and Survivin in cancer cells Mol. Cancer Ther. 2008, 7 (7) 1871-1879
9. Rybak, S. M.; Pearson, J. W.; Fogler, W. E.; Volker, K.; Spence, S. E.; Newton, D. L.; Mikulski, S. M.; Ardelt, W.; Riggs, C. W.; Kung, H. F.; Longo, D. L. Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonuclease J. Natl. Cancer Inst. 1996, 88 (11) 747-753
10. Tsai, S. Y.; Hsieh, T. C.; Ardelt, B.; Darzynkiewicz, Z.; Wu, J. M. Combined effects of onconase and IFN-beta on proliferation, macromolecular syntheses and expression of STAT-1 in JCA-1 cancer cells Int. J. Oncol. 2002, 20 (5) 891-896
11. Costanzi, J.; Sidransky, D.; Navon, A.; Goldsweig, H. Ribonucleases as a novel pro-apoptotic anticancer strategy: review of the preclinical and clinical data for ranpirnase Cancer Invest. 2005, 23 (7) 643-650
12. Vasandani, V. M.; Burris, J. A.; Sung, C. Reversible nephrotoxicity of onconase and effect of lysine pH on renal onconase uptake Cancer Chemother. Pharmacol. 1999, 44 (2) 164-169
13. Vasandani, V. M.; Wu, Y. N.; Mikulski, S. M.; Youle, R. J.; Sung, C. Molecular determinants in the plasma clearance and tissue distribution of ribonucleases of the ribonuclease A superfamily Cancer Res. 1996, 56 (18) 4180-4186
14. Rybak, S. M.; Newton, D. L. Natural and engineered cytotoxic ribonucleases: therapeutic potential Exp. Cell Res. 1999, 253 (2) 325-335
15. Bosch, M.; Benito, A.; Ribo, M.; Puig, T.; Beaumelle, B.; Vilanova, M. A nuclear localization sequence endows human pancreatic ribonuclease with cytotoxic activity Biochemistry 2004, 43 (8) 2167-2177
16. Rodriguez, M.; Benito, A.; Tubert, P.; Castro, J.; Ribo, M.; Beaumelle, B.; Vilanova, M. A cytotoxic ribonuclease variant with a discontinuous nuclear localization signal constituted by basic residues scattered over three areas of the molecule J. Mol. Biol. 2006, 360 (3) 548-557
17. Tubert, P.; Rodriguez, M.; Ribo, M.; Benito, A.; Vilanova, M. The nuclear transport capacity of a human-pancreatic ribonuclease variant is critical for its cytotoxicity Invest. New Drugs 2011, 29, 811-817
18. Castro, J.; Ribo, M.; Navarro, S.; Nogues, M. V.; Vilanova, M.; Benito, A. A human ribonuclease induces apoptosis associated with p21WAF1/CIP1 induction and JNK inactivation BMC Cancer 2011, 11, 9
19. Castro, J.; Ribo, M.; Puig, T.; Colomer, R.; Vilanova, M.; Benito, A. A cytotoxic ribonuclease reduces the expression level of P-glycoprotein in multidrug-resistant cell lines Invest. New Drugs 2012, 30, 880-888
20. Canals, A.; Ribo, M.; Benito, A.; Bosch, M.; Mombelli, E.; Vilanova, M. Production of engineered human pancreatic ribonucleases, solving expression and purification problems, and enhancing thermostability Protein Expression Purif. 1999, 17 (1) 169-181
21. Ribo, M.; Benito, A.; Canals, A.; Nogues, M. V.; Cuchillo, C. M.; Vilanova, M. Purification of engineered human pancreatic ribonuclease Methods Enzymol. 2001, 341, 221-234
22. Leland, P. A.; Schultz, L. W.; Kim, B. M.; Raines, R. T. Ribonuclease A variants with potent cytotoxic activity Proc. Natl. Acad. Sci. U.S.A. 1998, 95 (18) 10407-10412
23. Ribo, M.; Bosch, M.; Torrent, G.; Benito, A.; Beaumelle, B.; Vilanova, M. Quantitative analysis, using MALDI-TOF mass spectrometry, of the N-terminal hydrolysis and cyclization reactions of the activation process of onconase Eur. J. Biochem. 2004, 271 (6) 1163-1171
24. Pace, C. N.; Vajdos, F.; Fee, L.; Grimsley, G.; Gray, T. How to measure and predict the molar absorption coefficient of a protein Protein Sci. 1995, 4 (11) 2411-2423
25. Font, J.; Benito, A.; Torrent, J.; Lange, R.; Ribó, M.; Vilanova, M. Pressure- and temperature-induced unfolding studies: thermodynamics of core hydrophobicity and packing of ribonuclease A Biol. Chem. 2006, 387, 285-296
26. Torrent, J.; Connelly, J. P.; Coll, M. G.; Ribo, M.; Lange, R.; Vilanova, M. Pressure versus heat-induced unfolding of ribonuclease A: the case of hydrophobic interactions within a chain-folding initiation site Biochemistry 1999, 38 (48) 15952-15961
27. Boix, E.; Nogues, M. V.; Schein, C. H.; Benner, S. A.; Cuchillo, C. M. Reverse transphosphorylation by ribonuclease A needs an intact p2-binding site. Point mutations at Lys-7 and Arg-10 alter the catalytic properties of the enzyme J. Biol. Chem. 1994, 269 (4) 2529-2534
28. Pesic, M.; Markovic, J. Z.; Jankovic, D.; Kanazir, S.; Markovic, I. D.; Rakic, L.; Ruzdijic, S. Induced resistance in the human non small cell lung carcinoma (NCI-H460) cell line in vitro by anticancer drugs J. Chemother. 2006, 18 (1) 66-73
29. Benito, A.; Bosch, M.; Torrent, G.; Ribo, M.; Vilanova, M. Stabilization of human pancreatic ribonuclease through mutation at its N-terminal edge Protein Eng. 2002, 15 (11) 887-893
30. Fanara, P.; Hodel, M. R.; Corbett, A. H.; Hodel, A. E. Quantitative analysis of nuclear localization signal (NLS)-importin alpha interaction through fluorescence depolarization. Evidence for auto-inhibitory regulation of NLS binding J. Biol. Chem. 2000, 275 (28) 21218-21223
31. Pace, C. N.; Laurents, D. V.; Thomson, J. A. pH dependence of the urea and guanidine hydrochloride denaturation of ribonuclease A and ribonuclease T1 Biochemistry 1990, 29 (10) 2564-2572
32. Mondino, A.; Jenkins, M. K. Accumulation of sequence-specific RNA-binding proteins in the cytosol of activated T cells undergoing RNA degradation and apoptosis J. Biol. Chem. 1995, 270 (44) 26593-26601
33. Klink, T. A.; Raines, R. T. Conformational stability is a determinant of ribonuclease A cytotoxicity J. Biol. Chem. 2000, 275 (23) 17463-17467
34. Futami, J.; Maeda, T.; Kitazoe, M.; Nukui, E.; Tada, H.; Seno, M.; Kosaka, M.; Yamada, H. Preparation of potent cytotoxic ribonucleases by cationization: enhanced cellular uptake and decreased interaction with ribonuclease inhibitor by chemical modification of carboxyl groups Biochemistry 2001, 40 (25) 7518-2754
35. Ilinskaya, O. N.; Dreyer, F.; Mitkevich, V. A.; Shaw, K. L.; Pace, C. N.; Makarov, A. A. Changing the net charge from negative to positive makes ribonuclease Sa cytotoxic Protein Sci. 2002, 11 (10) 2522-2525
36. Ogawa, Y.; Iwama, M.; Ohgi, K.; Tsuji, T.; Irie, M.; Itagaki, T.; Kobayashi, H.; Inokuchi, N. Effect of replacing the aspartic acid/glutamic acid residues of bullfrog sialic acid binding lectin with asparagine/glutamine and arginine on the inhibition of cell proliferation in murine leukemia P388 cells Biol. Pharm. Bull. 2002, 25 (6) 722-727
37. Kover, K. E.; Bruix, M.; Santoro, J.; Batta, G.; Laurents, D. V.; Rico, M. The solution structure and dynamics of human pancreatic ribonuclease determined by NMR spectroscopy provide insight into its remarkable biological activities and inhibition J. Mol. Biol. 2008, 379 (5) 953-965
38. Gorlich, D.; Prehn, S.; Laskey, R. A.; Hartmann, E. Isolation of a protein that is essential for the first step of nuclear protein import Cell 1994, 79 (5) 767-778
39. Haigis, M. C.; Kurten, E. L.; Raines, R. T. Ribonuclease inhibitor as an intracellular sentry Nucleic Acids Res. 2003, 31 (3) 1024-1032
40. Johnson, R. J.; McCoy, J. G.; Bingman, C. A.; Phillips, G. N., Jr.; Raines, R. T. Inhibition of human pancreatic ribonuclease by the human ribonuclease inhibitor protein J. Mol. Biol. 2007, 368 (2) 434-449
41. Kiessling, L. L.; Gestwicki, J. E.; Strong, L. E. Synthetic multivalent ligands in the exploration of cell-surface interactions Curr. Opin. Chem. Biol. 2000, 4 (6) 696-703